• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.


— March 13, 2018

Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya

Read more

— Stock information


— February 26, 2018
Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate Against Zika Virus

Read more
— Financial Calendar

March 22, 2018
2017 Financial Statements

May 17, 2018
Q1 2018 Results

See all dates


learn more
play video Company Video

– Upcoming conferences

World Vaccine Congress
Washington, US
April 2-5, 2018

Please update your browser...